Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.47 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 1/20 | 0.47 |
| ▸ | CDK9 | P50750 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL958575 | 0.89 | FYN (0.52) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL3400297 | 0.88 | CCNT1 (0.52) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL12918930 | 0.86 | ABL1 (0.55) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL12918929 | 0.85 | CCNT1 (0.49) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL962081 | 0.85 | MAPT (0.48) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| Hydrochloric Acid SCHEMBL962334 | 0.85 | ABL1 (0.54) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL959846 | 0.85 | MAPT (0.48) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL961569 | 0.84 | MAPT (0.49) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL959130 | 0.82 | PTGDR (0.64) | MAPK1CCNT1CCNA2CDK2CDK9 | |
| SCHEMBL958199 | 0.82 | SMYD2 (0.51) | MAPK1CCNT1CCNA2CDK2CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110009421-A1 | COMPOUND HAVING 6-MEMBERED AROMATIC RING | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009421-A1 | COMPOUND HAVING 6-MEMBERED AROMATIC RING | GPR4, NR3C2, NR5A2 | MAPK1 2190/4885CCNT1 3526/4885CCNA2 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.